ZK 93426 hydrochloridePotent, competitive benzodiazepine antagonist CAS# 1216792-30-1 |
- Zoledronic Acid
Catalog No.:BCC1067
CAS No.:118072-93-8
- Go 6976
Catalog No.:BCC3703
CAS No.:136194-77-9
- Enzastaurin (LY317615)
Catalog No.:BCC1100
CAS No.:170364-57-5
- Chelerythrine chloride
Catalog No.:BCN8322
CAS No.:3895-92-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1216792-30-1 | SDF | Download SDF |
PubChem ID | 56972167 | Appearance | Powder |
Formula | C18H21ClN2O3 | M.Wt | 348.82 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in water and to 50 mM in DMSO | ||
Chemical Name | ethyl 4-methyl-5-propan-2-yloxy-9H-pyrido[3,4-b]indole-3-carboxylate;hydrochloride | ||
SMILES | CCOC(=O)C1=NC=C2C(=C1C)C3=C(N2)C=CC=C3OC(C)C.Cl | ||
Standard InChIKey | RNQJDOYVHCISJU-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C18H20N2O3.ClH/c1-5-22-18(21)17-11(4)15-13(9-19-17)20-12-7-6-8-14(16(12)15)23-10(2)3;/h6-10,20H,5H2,1-4H3;1H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Potent, selective and competitive benzodiazepine receptor antagonist (IC50 values are 0.4 and 0.7 nM for inhibition of [3H]-flunitrazepam binding to rat cerebellum and hippocampus respectively). Similar in vivo profile to flumazenil (Ro 15-1788); produces anxiogenic effects in some behavioral tests and anxiolytic effects in others. Orally active. |
ZK 93426 hydrochloride Dilution Calculator
ZK 93426 hydrochloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.8668 mL | 14.334 mL | 28.6681 mL | 57.3362 mL | 71.6702 mL |
5 mM | 0.5734 mL | 2.8668 mL | 5.7336 mL | 11.4672 mL | 14.334 mL |
10 mM | 0.2867 mL | 1.4334 mL | 2.8668 mL | 5.7336 mL | 7.167 mL |
50 mM | 0.0573 mL | 0.2867 mL | 0.5734 mL | 1.1467 mL | 1.4334 mL |
100 mM | 0.0287 mL | 0.1433 mL | 0.2867 mL | 0.5734 mL | 0.7167 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- GSK 4112
Catalog No.:BCC7741
CAS No.:1216744-19-2
- BYK 191023 dihydrochloride
Catalog No.:BCC7506
CAS No.:1216722-25-6
- SCH 79797 dihydrochloride
Catalog No.:BCC7125
CAS No.:1216720-69-2
- Trap 101
Catalog No.:BCC7390
CAS No.:1216621-00-9
- 2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxaldehyde
Catalog No.:BCC8573
CAS No.:121660-37-5
- 2-Cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-methanol
Catalog No.:BCC8574
CAS No.:121660-11-5
- ZK 93423 hydrochloride
Catalog No.:BCC7227
CAS No.:1216574-52-5
- BX 513 hydrochloride
Catalog No.:BCC5940
CAS No.:1216540-18-9
- Kaempferol-3-O-(2',6'-di-O-trans-p-coumaroyl)-beta-D-glucopyranoside
Catalog No.:BCN1603
CAS No.:121651-61-4
- SB 258585 hydrochloride
Catalog No.:BCC7216
CAS No.:1216468-02-8
- YM 298198 hydrochloride
Catalog No.:BCC7366
CAS No.:1216398-09-2
- 6-Demethoxycleomiscosin A
Catalog No.:BCN7299
CAS No.:121587-20-0
- CGP 20712 dihydrochloride
Catalog No.:BCC6893
CAS No.:1216905-73-5
- Sarafotoxin S6c
Catalog No.:BCC5721
CAS No.:121695-87-2
- Moluccanin
Catalog No.:BCN6107
CAS No.:121700-26-3
- Moluccanin diacetate
Catalog No.:BCN6108
CAS No.:121700-27-4
- PTC209 HBr
Catalog No.:BCC5640
CAS No.:1217022-63-3
- BU 239 hydrochloride
Catalog No.:BCC5668
CAS No.:1217041-98-9
- GYKI 47261 dihydrochloride
Catalog No.:BCC7566
CAS No.:1217049-32-5
- 6-O-p-Methoxycinnamoylcatalpol
Catalog No.:BCN6109
CAS No.:121710-02-9
- CP 31398 dihydrochloride
Catalog No.:BCC2406
CAS No.:1217195-61-3
- A 350619 hydrochloride
Catalog No.:BCC5939
CAS No.:1217201-17-6
- VD2-D3
Catalog No.:BCC2034
CAS No.:1217448-46-8
- Ro 26-4550 trifluoroacetate
Catalog No.:BCC5813
CAS No.:1217448-66-2
Enhancement of gamma-aminobutyric acid binding by the anxiolytic beta-carbolines ZK 93423 and ZK 91296.[Pubmed:2881979]
J Neurochem. 1987 May;48(5):1355-8.
The effects of two anxiolytic beta-carboline derivatives, ZK 93423 and ZK 91296, on the binding of gamma-[3H]aminobutyric acid ([3H]GABA) to brain membrane preparations from rat cerebral cortex were examined. ZK 93423 concentration-dependently enhanced the specific binding of [3H]GABA, with a maximal increase of 45% above control at a 50 microM concentration. A less pronounced increase was induced by diazepam and by the partial agonist ZK 91296. Scatchard plot analysis revealed that the effect of ZK 93423 was due to an increase in the total number of high- and low-affinity GABA binding sites. The action of ZK 93423 was mediated by benzodiazepine recognition sites since it was blocked by the benzodiazepine antagonists Ro 15-1788 and ZK 93426 at concentrations that failed to modify [3H]GABA binding on their own. Moreover the stimulatory effect of ZK 93423 on [3H]GABA binding was also blocked by the beta-carboline inverse agonist ethyl beta-carboline-3-carboxylate. These results are consistent with the view that ZK 93423 and ZK 91296, similarly to benzodiazepines, exert their pharmacological effects by enhancing the GABAergic transmission at the level of the GABA/benzodiazepine receptor complex.
Effects of beta-carbolines in animal models of anxiety.[Pubmed:3315125]
Brain Res Bull. 1987 Sep;19(3):293-9.
Animal models of anxiety can be classified into three main groups: those based on conflict or conditioned fear; those exploiting the anxiety produced by novelty; those in which anxiety or aversion is chemically induced. This review briefly describes the existing tests and, where available, the results obtained with beta-carbolines. Many of the beta-carbolines are anxiogenic in the tests, however ZK 91296 and ZK 93423 appear to have anxiolytic properties, and ZK 93426 has a similar profile to that of the benzodiazepine receptor antagonist RO 15-1788. By the results across the spectrum of tests, the reliability and sensitivity of the tests is assessed. The evidence that the anxiogenic and anxiolytic actions of the beta-carbolines are mediated by the BDZ binding sites is also discussed.
Evaluation of the beta-carboline ZK 93 426 as a benzodiazepine receptor antagonist.[Pubmed:6089247]
Psychopharmacology (Berl). 1984;83(3):249-56.
We describe here biochemical and pharmacological effects of the beta-carboline ZK 93426 was compared with Ro 15-1788 and CGS 8216, two compounds previously described as BZ receptor antagonists. Certain effects of ZK 93426, Ro 15-1788 and CGS 8216 were quite similar (e.g., 3H-FNM displacement, "GABA ratio", "photo-shift"). In most pharmacological tests ZK 93426 and Ro 15-1788 lacked overt effects; Ro 15-1788 was a weak agonist in some paradigms, while ZK 93426 exhibited a potent proconflict effect but also a weak anticonvulsant effect. This interesting finding with ZK 93426 suggests that BZ receptor ligands may possess differential efficacy at BZ receptor subtypes. In contrast, CGS 8216 exhibited potent proconvulsant effects in several paradigms in addition to proconflict and pentylenetetrazol generalizing effects. ZK 93426, Ro 15-1788 and CGS 8216 were almost equally potent as antagonists of the effects of BZ receptor agonists, such as diazepam and lorazepam. However, ZK 93426 was the most potent inhibitor of the convulsions produced by the BZ receptor inverse agonist DMCM.